Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, controlled trial in the Pediatric Emergency Department.
The primary objective is to determine whether nebulized 3% hypertonic saline is more
effective than nebulized 0.9% saline in the treatment of bronchiolitis in the emergency
department.